HEERMA PETER (Chief Commercial Officer) sold 4.2% of their position (4.98K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $199.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/29/2025ACC: 0001789617-25-000009
Officer· Chief Commercial Officer
Since Oct 2019
-4.98K
Net shares
Net seller
$199.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.98K
Price / share
$40.00
Trade value
$199.20K
% of position
4.2%
12/24/2025
117.99K→113.01K
Total
Net shares
−4.98K
Net value
-$199.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/24/2025 | S · Sale | −4.98K | $40.00 | $199.20K | 4.2% | 117.99K | 113.01K |
| Total | −4.98K | -$199.20K | ||||||
Derivative Transactions0
No derivative transactions reported